Frequency of Prostate-Specific Antigen Screening in African American Men in the San Francisco Area

This study is currently recruiting participants.

Verified by National Cancer Institute (NCI), December 2008

Sponsors and Collaborators:	UCSF Helen Diller Family Comprehensive Cancer Center National Cancer Institute (NCI)
Information provided by:	National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:	NCT00702104

Purpose

RATIONALE: Screening may help doctors find prostate cancer sooner, when it may be easier to treat.

PURPOSE: This research study is looking at whether patients who are being screened for prostate cancer have been previously screened.

Condition	Intervention
Prostate Cancer	Procedure: survey administration

MedlinePlus related topics: Cancer Prostate Cancer

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Health Services Research, Open Label
Official Title:	PSA Screening of African-American Men in The San Francisco Area

Further study details as provided by National Cancer Institute (NCI):

Primary Outcome Measures:

Degree to which patients who are being screened for prostate cancer have been previously screened [ Designated as safety issue: No ]

Estimated Enrollment:	175
Study Start Date:	August 2002
Estimated Primary Completion Date:	August 2022 (Final data collection date for primary outcome measure)

Detailed Description:

OBJECTIVES:

Primary

To determine the degree to which patients who are being screened for prostate cancer have been previously screened.

OUTLINE: Participants complete questions on a survey about prior prostate-specific antigen blood tests done for the purpose of screening for prostate cancer and are asked about their pastor, church, and how they heard about the SELECT study to determine the degree to which African-American men in a church-going population have been previously screened.

Eligibility

Ages Eligible for Study:	35 Years and older
Genders Eligible for Study:	Male
Accepts Healthy Volunteers:	No

Criteria

DISEASE CHARACTERISTICS:

Meets all of the following criteria:
- African-American male
- Age 35 years or older
- Attends church on a regular basis
- Resides in the San Francisco area

PATIENT CHARACTERISTICS:

Not specified

PRIOR CONCURRENT THERAPY:

Not specified

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00702104

Locations

United States, California
UCSF Helen Diller Family Comprehensive Cancer Center	Recruiting
San Francisco, California, United States, 94115
Contact: Clinical Trials Office - UCSF Helen Diller Family Comprehensi 877-827-3222

Sponsors and Collaborators

UCSF Helen Diller Family Comprehensive Cancer Center

National Cancer Institute (NCI)

Investigators

Investigator:

Mack Roach, MD

UCSF Helen Diller Family Comprehensive Cancer Center

More Information

Clinical trial summary from the National Cancer Institute's PDQ® database This link exits the ClinicalTrials.gov site

Study ID Numbers:	CDR0000596996, UCSF-0555105, UCSF-H7056-21713-06
Study First Received:	June 19, 2008
Last Updated:	December 16, 2008
ClinicalTrials.gov Identifier:	NCT00702104
Health Authority:	Unspecified

Keywords provided by National Cancer Institute (NCI):

prostate cancer

Study placed in the following topic categories:

Prostatic Diseases
Genital Neoplasms, Male
Urogenital Neoplasms
Genital Diseases, Male
Prostatic Neoplasms

Additional relevant MeSH terms:

Neoplasms
Neoplasms by Site

ClinicalTrials.gov processed this record on January 15, 2009